Latest Ratings for PCRX
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Wedbush | Maintains | Outperform | |
| Feb 2022 | HC Wainwright & Co. | Maintains | Buy | |
| Jan 2022 | Barclays | Maintains | Overweight |
Evaluating Pacira BioSciences: Insights From 8 Financial Analysts
Where Today's News Shapes Tomorrow
